The U.S. health care system is often touted as a bastion of free-market principles, yet a closer examination reveals a landscape riddled with contradictions that challenge this notion and expose deep-rooted issues. With annual health care spending surpassing $4 trillion, the stakes are enormous,
The biotechnology sector often rides a rollercoaster of high hopes and sharp setbacks, and few cases illustrate this better than the recent plunge in Exelixis’ stock value following the release of data from its STELLAR-303 trial. Focused on zanzalintinib, an experimental drug for metastatic
In a stunning turn of events that has captured national attention, a Los Angeles jury recently ordered Johnson & Johnson, a multinational giant in the healthcare industry, to pay a staggering $966 million to the family of Mae Moore, a California resident who tragically passed away in 2021 from
The startling reality that over 30% of adults may carry dangerous fat deposits deep within their abdomen or liver, even without visible signs of obesity, has sparked intense discussion in the medical community. This hidden fat, often undetectable through traditional measures like body mass index
In a startling revelation that has caught the attention of the medical community, a popular medication used for weight loss and diabetes management, Ozempic, may pose an unexpected challenge in the realm of diagnostic imaging. Known for its effectiveness in controlling blood sugar and aiding
In the quiet corridors of cancer research, a seismic shift is stirring for those battling multiple myeloma, a blood cancer that relentlessly challenges both patients and clinicians, igniting hope for a breakthrough. Picture a patient, exhausted after rounds of treatment, hoping for a breakthrough
Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research, development, and innovation within the biotechnology industry. With a deep understanding of the latest technologies and trends, Ivan offers invaluable insights into the world of
In an era where healthcare is becoming increasingly data-driven, a groundbreaking artificial intelligence system known as InfEHR (Inference on Electronic Health Records) is poised to redefine medical diagnostics with unprecedented precision. Developed through a collaboration led by researchers at
In a landscape where healthcare should prioritize patient well-being above all, the Malaysian Medical Association (MMA) has raised a critical alarm about the increasing influence of corporate entities on medical decisions, threatening the ethical foundation of the profession. As articulated by its
Breast cancer remains a significant global health challenge, affecting millions of lives with its high prevalence and mortality rates, as evidenced by over 2.3 million women diagnosed worldwide in a single year and nearly 670,000 deaths. This alarming reality highlights the urgent need for
